Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to December 2025, from the company's annual filing with the SEC.
| Salesyearly sales | $20.3B |
| Sales growthchange from the year before | +48.6% |
| Gross marginshare of sales left after the direct cost of what it sells | 20.6% |
| Operating marginshare of sales left after running the business | 9.3% |
| Net marginshare of sales kept as profit | 6.9% |
| Free-cash-flow marginspare cash generated per $100 of sales | 4.4% |
| Return on invested capitalprofit made on each $100 put into the business | 17.8% |
| Return on equityprofit vs. shareholders' accounting value | 40.9% |
| Debt / equitydebt vs. shareholders' accounting value | 1.43 |
| Change in share countnegative = the company is buying back its shares | +69.6% |
1 insider bought $1.5M; 3 insiders sold $7.7M (all under pre-arranged plans) on the open market.
| Huston Benjamin E.Chief Operating Officer | Sold (plan)Aug 3 | 50,000 shat $64.50 · $3.2M |
| Jenkins Mark W.Chief Financial Officer | Sold (plan)Aug 3 | 63,750 shat $64.50 · $4.1M |
| Palmer Stephen RVice President of Accounting | Sold (plan)Aug 3 | 5,000 shat $64.49 · $322K |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy